Clinical Trials Browser

Phase 1 × merestinib × Other hematologic neoplasm × Clear all

NCT03125239 2020-06-30

Combination Merestinib and LY2874455 for Patients With Relapsed or Refractory Acute Myeloid Leukemia

Phase 1 Completed

Other hematologic neoplasm

Leukemia, Myeloid, Acute